Back
WuXi Biologics (Cayman) Quote, Financials, Valuation and Earnings
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
50
WXXWY
WuXi Biologics (Cayman)
Last Price:
3.85
Seasonality Move:
9.61%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More HereWuXi Biologics (Cayman) Price Quote
$3.85
-0.16 (-3.99%)
(Updated: November 14, 2024 at 1:20 PM ET)
WuXi Biologics (Cayman) Key Stats
Sell
50
WuXi Biologics (Cayman) (WXXWY)
is a Sell
Day range:
$3.97 - $4.10
52-week range:
$2.58 - $13.25
Dividend yield:
0%
P/E ratio:
19.06
P/S ratio:
3.75
P/B ratio:
1.52%
Volume:
19.4K
Avg. volume:
77.9K
1-year change:
-68.1%
Market cap:
$8.5B
Revenue:
$2.4B
EPS:
$0.17
How Much Does WuXi Biologics (Cayman) Make?
-
How Much Are WuXi Biologics (Cayman)'s Sales Annually?
WXXWY Revenues are $2.4B -
How Much Profit Does WuXi Biologics (Cayman)'s Make A Year?
WXXWY net income is $480.6M
Is WuXi Biologics (Cayman) Growing As A Company?
Data Unavailable
WuXi Biologics (Cayman) Stock Price Performance
-
Did WuXi Biologics (Cayman) Stock Go Up Last Month?
WuXi Biologics (Cayman) share price went down by -12.83% last month -
Did WXXWY's Share Price Rise Over The Last Year?
WXXWY share price fell by -68.1% over the past 1 year
What Is WuXi Biologics (Cayman) 52-Week High & Low?
-
What Is WuXi Biologics (Cayman)’s 52-Week High Share Price?
WuXi Biologics (Cayman) has traded as high as $13.25 over the past 52 weeks -
What Is WuXi Biologics (Cayman)’s 52-Week Low Share Price?
WuXi Biologics (Cayman) has traded as low as $2.58 over the past 52 weeks
WuXi Biologics (Cayman) Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy WuXi Biologics (Cayman)?
-
How Much Debt Does WuXi Biologics (Cayman) Have?
Total long term debt quarterly is $296.8M -
How Much Cash Does WuXi Biologics (Cayman) Have?
Cash and short term investments quarterly total is $1.3B -
What Is WuXi Biologics (Cayman)’s Book Value Per Share?
Book value per share is 2.69
Is WuXi Biologics (Cayman) Cash Flow Positive?
-
What Is WXXWY Cash Flow From Operations?
Cash flow from operations (TTM) is $447.4M -
What Is WuXi Biologics (Cayman)’s Cash Flow From Financing?
Cash flow from financing (TTM) is $93.4M -
What Is WuXi Biologics (Cayman)’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$280.9M
WuXi Biologics (Cayman) Return On Invested Capital
-
Is Management Doing A Good Job?
WXXWY return on invested capital is 5.86% -
What Is WuXi Biologics (Cayman) Return On Assets?
ROA measures how assets are converting to revenues and is 4.8% -
What Is WXXWY Return On Equity?
ROE is a measure of profitability and is 6.19%
WuXi Biologics (Cayman) Earnings Date & Stock Price
-
What Is WuXi Biologics (Cayman)'s Stock Price Today?
A single share of WXXWY can be purchased today for 4.01 -
What Is WuXi Biologics (Cayman)’s Stock Symbol?
WuXi Biologics (Cayman) trades on the otcm under the ticker symbol: WXXWY -
When Is WuXi Biologics (Cayman)’s Next Earnings Date?
The next quarterly earnings date for WuXi Biologics (Cayman) is scheduled on March 26, 2025 -
When Is WXXWY's next ex-dividend date?
WuXi Biologics (Cayman)'s next ex-dividend date is November 14, 2024 -
How To Buy WuXi Biologics (Cayman) Stock?
You can buy WuXi Biologics (Cayman) shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
WuXi Biologics (Cayman) Competitors
-
Who Are WuXi Biologics (Cayman)'s Competitors?
Below is a list of companies who compete with WuXi Biologics (Cayman) or are related in some way:
WuXi Biologics (Cayman) Dividend Yield
-
What Is WXXWY Dividend Yield?
WuXi Biologics (Cayman)’s dividend yield currently is 0% -
What Is WuXi Biologics (Cayman)’s Payout Ratio?
WuXi Biologics (Cayman)’s payout ratio is 0% -
When Did WuXi Biologics (Cayman) Last Pay A Dividend?
The latest dividend pay date is November 14, 2024 -
What Is WuXi Biologics (Cayman)’s Dividend Per Share?
WuXi Biologics (Cayman) pays a dividend of $0.00 per share
WuXi Biologics (Cayman) Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |